CiMaas appoints Professor Dr J. Aerts and Professor Dr J. Haanen to the Scientific Advisory Board
As of 18 february 2016 CiMaas has appointed the renowned oncologists Professor Dr Joachim Aerts and Professor Dr John Haanen […]
News
News
CiMaas receives subsidy from the Limburg Province (through LBDF) to develop an antibody prototype that will increase NK cell activity
CiMaas focuses on the development of cellular immunotherapy for the treatment of cancer. One of these therapies is based on
News
CiMaas BV and PharmaCell BV enter a collaborative agreement
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies
News
CiMaas appoints Dr. Yvo Graus as Chief Operating Officer
Dr Yvo Graus, PhD, MBA, will join the management team of CiMaas. Yvo Graus is an immunologist and has extensive
News
CiMaas appoints Drs D.A. van den Noort in Supervisory Board
Drs D.A. van den Noort, MD, and member of the Board of Directors of Bioseutica, has been appointed as first
News
CiMaas has been nominated for the Innovaward 2015
Out of 75 applicants, 20 young companies have been nominated to receive an innovation award in November 2015. CiMaas is